Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway

Author:            

Publisher: Spandidos Publications

ISSN: 1019-6439

Source: International Journal of Oncology, Vol.45, Iss.2, 2014-01, pp. : 651-658

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content